Global Markets Direct’s, ‘Degenerative Disc Disease - Pipeline Review, H2 2019’, provides an overview of the Degenerative Disc Disease pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Degenerative Disc Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, t...

Global Markets Direct’s, ‘Osteoarthritis - Pipeline Review, H1 2019’, provides an overview of the Osteoarthritis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Osteoarthritis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of...

Global Markets Direct’s, ‘Sarcopenia - Pipeline Review, H1 2019’, provides an overview of the Sarcopenia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Sarcopenia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players...

Global Markets Direct’s, ‘Inclusion Body Myositis (IBM) - Pipeline Review, H2 2018’, provides an overview of the Inclusion Body Myositis (IBM) pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Inclusion Body Myositis (IBM), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Add...

Global Markets Direct’s, ‘Muscle Atrophy - Pipeline Review, H2 2018’, provides an overview of the Muscle Atrophy pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Muscle Atrophy, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of...

Global Markets Direct’s, ‘Achondroplasia - Pipeline Review, H2 2018’, provides an overview of the Achondroplasia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Achondroplasia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of...

Global Markets Direct’s, ‘Bone Fracture - Pipeline Review, H2 2018’, provides an overview of the Bone Fracture pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Bone Fracture, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of ke...

Global Markets Direct’s, ‘Systemic Idiopathic Juvenile Arthritis - Pipeline Review, H2 2018’, provides an overview of the Systemic Idiopathic Juvenile Arthritis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Systemic Idiopathic Juvenile Arthritis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest n...

Global Markets Direct’s, ‘Prosthetic joint infections - Pipeline Review, H1 2018’, provides an overview of the Prosthetic joint infections pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Prosthetic joint infections, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additiona...

Global Markets Direct’s, ‘Fibrodysplasia Ossificans Progressiva (Myositis Ossificans Progressiva) - Pipeline Review, H1 2018’, provides an overview of the Fibrodysplasia Ossificans Progressiva (Myositis Ossificans Progressiva) pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Fibrodysplasia Ossificans Progressiva (Myositis Ossificans Progressiva), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pha...

Global Markets Direct’s, ‘Psoriatic Arthritis - Pipeline Review, H1 2018’, provides an overview of the Psoriatic Arthritis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Psoriatic Arthritis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides...

Global Markets Direct’s, ‘Axial Spondyloarthritis - Pipeline Review, H1 2018’, provides an overview of the Axial Spondyloarthritis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Axial Spondyloarthritis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the rep...

Global Markets Direct’s, ‘Gouty Arthritis (Gout) - Pipeline Review, H1 2018’, provides an overview of the Gouty Arthritis (Gout) pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Gouty Arthritis (Gout), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report...

Global Markets Direct’s, ‘Pigmented Villonodular Synovitis - Pipeline Review, H1 2018’, provides an overview of the Pigmented Villonodular Synovitis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Pigmented Villonodular Synovitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press rele...

Global Markets Direct’s, ‘Muscular Dystrophy - Pipeline Review, H1 2018’, provides an overview of the Muscular Dystrophy pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Muscular Dystrophy, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...